Literature DB >> 35273468

National FluWatch mid-season report, 2021-2022: Sporadic influenza activity returns.

Christina Bancej1, Abbas Rahal1, Liza Lee1, Steven Buckrell1, Kara Schmidt1, Nathalie Bastien2.   

Abstract

Surveillance for Canada's 2021-2022 seasonal influenza epidemic began in epidemiological week 35 (the week starting August 29, 2021) during the ongoing coronavirus disease 2019 (COVID-19) global public health emergency. In the 2021-2022 surveillance season to date, there has been a return of persistent sporadic influenza activity, and the first influenza-associated hospitalizations since mid-2020 have been reported. However, as of week 52 (week ending 01/01/2022) activity has remained sporadic, and no influenza-confirmed outbreaks or epidemic activity have been detected. There has been a delay or absence in several traditional seasonal influenza milestones, including the declared start of the influenza season, marked by a threshold of 5% positivity, which historically has occurred on average in week 47. The 429 sporadic detections reported in Canada to date have occurred in 31 regions across seven provinces/territories. Nearly half (n=155/335, 46.3%) of reported cases have been in the paediatric (younger than 19 years) population. Three-quarters of the cases were influenza A detections (n=323/429, 75.3%). Of the subtyped influenza A detections, A(H3N2) predominated (n=83/86, 96.5%). Of the 12 viruses characterized by the National Microbiology Laboratory, 11 were seasonal strains. Among the seasonal strains characterized, only one was antigenically similar to the strains recommended for the 2021-2022 Northern Hemisphere vaccine, though all were sensitive to the antivirals, oseltamivir and zanamivir. Until very recently, seasonal influenza epidemics had not been reported since March 2020. Evidence on the re-emergence of seasonal influenza strains in Canada following the A(H1N1)pdm09 pandemic shows that influenza A(H3N2) and B epidemics ceased through the 2009-2010 season and second wave of A(H1N1)pdm09, but then re-emerged in subsequent seasons to predominate causing epidemics of higher intensity than in the pre-pandemic seasons. When and where seasonal influenza epidemic activity resumes cannot be predicted, but model-based estimates and historical post-pandemic patterns of intensified epidemics warrant continued vigilance through the usual season and for out-of-season re-emergence. In addition, ongoing population preparedness measures, such as annual influenza vaccination to mitigate the intensity and burden of future seasonal influenza epidemic waves, should continue.

Entities:  

Keywords:  : influenza; Canada; human/epidemiology; human/virology; influenza A virus; influenza B virus; non-pharmaceutical interventions; seasons; surveillance

Year:  2022        PMID: 35273468      PMCID: PMC8856831          DOI: 10.14745/ccdr.v48i01a06

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  16 in total

1.  Impact of nonpharmaceutical interventions on laboratory detections of influenza A and B in Canada.

Authors:  Philippe Lagacé-Wiens; Claire Sevenhuysen; Liza Lee; Andrea Nwosu; Tiffany Smith
Journal:  Can Commun Dis Rep       Date:  2021-03-31

2.  Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design.

Authors:  Julia Stowe; Elise Tessier; H Zhao; Rebecca Guy; Berit Muller-Pebody; Maria Zambon; Nick Andrews; Mary Ramsay; Jamie Lopez Bernal
Journal:  Int J Epidemiol       Date:  2021-05-03       Impact factor: 7.196

3.  Estimating influenza deaths in Canada, 1992-2009.

Authors:  Dena L Schanzer; Claire Sevenhuysen; Brian Winchester; Teresa Mersereau
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

4.  The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections.

Authors:  Rachel E Baker; Sang Woo Park; Wenchang Yang; Gabriel A Vecchi; C Jessica E Metcalf; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-09       Impact factor: 11.205

5.  Clinical and virological impact of single and dual infections with influenza A (H1N1) and SARS-CoV-2 in adult inpatients.

Authors:  Jiazhen Zheng; Fengjuan Chen; Keyi Wu; Jiancheng Wang; Furong Li; Shan Huang; Jianyun Lu; Jinghan Huang; Huamin Liu; Rui Zhou; Zhiwei Huang; Bingyao Meng; Zelin Yuan; Xianbo Wu
Journal:  PLoS Negl Trop Dis       Date:  2021-11-29

6.  Leveraging Global Influenza Surveillance and Response System for the COVID-19 Pandemic Response and Beyond.

Authors:  Aspen Hammond; Vanessa Cozza; Siddhi Hirve; Marie-Jo Medina; Dmitriy Pereyaslov; Wenqing Zhang
Journal:  China CDC Wkly       Date:  2021-10-29

7.  Burden of influenza, respiratory syncytial virus, and other respiratory viruses and the completeness of respiratory viral identification among respiratory inpatients, Canada, 2003-2014.

Authors:  Dena L Schanzer; Myriam Saboui; Liza Lee; Andrea Nwosu; Christina Bancej
Journal:  Influenza Other Respir Viruses       Date:  2017-12-15       Impact factor: 4.380

8.  Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020.

Authors:  Ian G Barr; Erik A Karlsson; Jurre Y Siegers; Vijaykrishna Dhanasekaran; Ruopeng Xie; Yi-Mo Deng; Sarika Patel; Vanra Ieng; Jean Moselen; Heidi Peck; Ammar Aziz; Borann Sarr; Savuth Chin; Seng Heng; Asheena Khalakdina; Michael Kinzer; Darapheak Chau; Philomena Raftery; Veasna Duong; Ly Sovann
Journal:  J Virol       Date:  2021-09-29       Impact factor: 5.103

9.  Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020.

Authors:  Danuta M Skowronski; Macy Zou; Suzana Sabaiduc; Michelle Murti; Romy Olsha; James A Dickinson; Jonathan B Gubbay; Matthew A Croxen; Hugues Charest; Agatha Jassem; Mel Krajden; Nathalie Bastien; Yan Li; Gaston De Serres
Journal:  Euro Surveill       Date:  2020-02

10.  Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020.

Authors:  Sheena G Sullivan; Sandra Carlson; Allen C Cheng; Monique Bn Chilver; Dominic E Dwyer; Melissa Irwin; Jen Kok; Kristine Macartney; Jennifer MacLachlan; Cara Minney-Smith; David Smith; Nigel Stocks; Janette Taylor; Ian G Barr
Journal:  Euro Surveill       Date:  2020-11
View more
  1 in total

Review 1.  The effects of the COVID-19 pandemic on community respiratory virus activity.

Authors:  Eric J Chow; Timothy M Uyeki; Helen Y Chu
Journal:  Nat Rev Microbiol       Date:  2022-10-17       Impact factor: 78.297

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.